Inventiva (IVA)
(Delayed Data from NSDQ)
$3.64 USD
+0.14 (4.00%)
Updated Aug 7, 2025 03:59 PM ET
After-Market: $3.58 -0.06 (-1.65%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Inventiva S.A. Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IVA 3.64 +0.14(4.00%)
Will IVA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IVA
Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock?
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year?
IVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for IVA
12 Health Care Stocks Moving In Friday's Intraday Session
Inventiva (IVA) Welcomes New Leadership in R&D and Medical Management | IVA Stock News
Inventiva CMO Michael Cooreman to depart, Jason Campagna to succeed
Inventiva receives $10M milestone payment from Chia Tai-Tianqing Pharmaceutical
12 Health Care Stocks Moving In Wednesday's After-Market Session